slides · global inventory
Chart
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 78,138
Current window 66,631-66,660
Pages 2,605
Rows per page 30
Component
66,631-66,660 of 78,138
30
The chart shows tumor volume over time (days) for four groups, demonstrating synergistic efficacy of the dual gene therapy.Genprex | Investor Presentation Deck | 58 slides · Genprex
Pitch deck Investor relations Beat · Visualization1 hit
36
The slide uses a pie chart to illustrate the prevalence split between T1D and T2D.Genprex | Investor Presentation Deck | 58 slides · Genprex
Pitch deck Investor relations Beat · Visualization1 hit
43
The data shows a significant improvement in glucose regulation post-therapy, closely tracking the normal NHP curve.Genprex | Investor Presentation Deck | 58 slides · Genprex
Pitch deck Investor relations 1 hit
56
Includes bioluminescence imaging of tumor xenografts and bar charts quantifying Active T cells, MDSC, Active NK cells, and DC populations.Genprex | Investor Presentation Deck | 58 slides · Genprex
Pitch deck Investor relations 1 hit
09
The chart uses a trend line to highlight the improvement over five years.Grove | Investor Presentation Deck | 35 slides · Grove Collaborative
Pitch deck Investor relations Beat · TractionLoop · Cost Of Inaction1 hit
10
The chart shows a clear downward trend in SG&A expenses over time, with a specific callout for a Q1-2024 restructuring gain.Grove | Investor Presentation Deck | 35 slides · Grove Collaborative
Pitch deck Investor relations Beat · TractionLoop · Cost Of Inaction1 hit
14
The chart illustrates cohort decay and stabilization over time.Grove | Investor Presentation Deck | 35 slides · Grove Collaborative
Pitch deck Investor relations Beat · TractionLoop · Cost Of Inaction1 hit
17
The slide uses a testimonial to reinforce the strategic shift into new categories.Grove | Investor Presentation Deck | 35 slides · Grove Collaborative
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
18
The chart uses a dual-axis approach (implied) to show growth trends for two different metrics over time, with a 'Runway For Growth' arrow highlighting the upward trajectory.Grove | Investor Presentation Deck | 35 slides · Grove Collaborative
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
19
The chart uses a legend for categories and arrows to indicate growth percentages between periods.Grove | Investor Presentation Deck | 35 slides · Grove Collaborative
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
20
VMS likely stands for Vitamins, Minerals, and Supplements.Grove | Investor Presentation Deck | 35 slides · Grove Collaborative
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
28
The chart highlights a 'pandemic bump' in 2020-2021 and projects a return to positive EBITDA in 2024.Grove | Investor Presentation Deck | 35 slides · Grove Collaborative
Pitch deck Investor relations Beat · Financials1 hit
29
The chart uses a visual arrow to emphasize the projected growth trend from Q3 to Q4.Grove | Investor Presentation Deck | 35 slides · Grove Collaborative
Pitch deck Investor relations Beat · Financials1 hit
07
The slide uses a bar chart to visually demonstrate the 'higher standard' of the company's ingredient policy compared to regional regulations.Honest | Investor Presentation Deck | 36 slides · Honest
Pitch deck Investor relations Beat · Solution1 hit
09
The slide uses a donut chart to visualize revenue distribution across three segments.Honest | Investor Presentation Deck | 36 slides · Honest
Pitch deck Investor relations Beat · Traction1 hit
16
The chart illustrates a clear trend of improving financial performance over the course of 2023.Honest | Investor Presentation Deck | 36 slides · Honest
Pitch deck Investor relations Beat · Traction1 hit
30
The chart uses a stacked bar approach to show current reach vs. potential opportunity.Honest | Investor Presentation Deck | 36 slides · Honest
Pitch deck Investor relations Beat · Market Size1 hit
31
The slide uses a grouped bar chart to show that Honest products have significantly lower distribution (ACV %) compared to key competitors across four product categories.Honest | Investor Presentation Deck | 36 slides · Honest
Pitch deck Investor relations 1 hit
32
The slide highlights a significant gap in shelf presence, suggesting an opportunity for growth.Honest | Investor Presentation Deck | 36 slides · Honest
Pitch deck Investor relations 1 hit
11
The chart uses a bridge format to explain a 50 basis point decline in gross margin.Hugo Boss | Results Presentation Deck | 20 slides · Hugo Boss
Conference presentation Investor relations Loop · Before After1 hit
10
Includes footnotes explaining calculation methodology and specific adjustments for Q3 2024.Hyzon | Results Presentation Deck | 13 slides · Hyzon
Conference presentation Investor relations Beat · ActionLoop · Cost Of Inaction1 hit
05
The chart uses a 2x2 matrix structure to categorize peer performance based on volatility and returns.International General Insurance | Investor Presentation Deck | 20 slides · International General Insurance
Pitch deck Investor relations Loop · Mece Breakdown1 hit
12
The chart overlays IGIC Combined Ratio (line) against Industry Cat Losses (stacked bars) with annotations for specific major catastrophe events.International General Insurance | Investor Presentation Deck | 20 slides · International General Insurance
Pitch deck Investor relations Loop · Golden Circle1 hit
14
The chart illustrates the components of net sales change between two periods.Kenvue | Results Presentation Deck | 41 slides · Kenvue
Conference presentation Investor relations Beat · SatisfactionLoop · So What Cascade1 hit
07
The slide uses a growth curve to visualize facility ramp-ups and milestones from 1H22 to 2030.Legend Biotech | Results Presentation Deck | 17 slides · Legend Biotech
Conference presentation Investor relations 1 hit
08
The chart shows a stacked bar chart of quarterly sales from Q2 2022 to Q3 2024.Legend Biotech | Results Presentation Deck | 17 slides · Legend Biotech
Conference presentation Investor relations Beat · KPI OverviewLoop · Voice Of Customer1 hit
10
The chart is a 3D pie chart showing the split between Inpatient and Outpatient settings.Legend Biotech | Results Presentation Deck | 17 slides · Legend Biotech
Conference presentation Investor relations 1 hit
13
The waterfall chart shows a bridge from 145 to 175, with a 30 unit increase. The R&D delta is shown as 0.Legend Biotech | Results Presentation Deck | 17 slides · Legend Biotech
Conference presentation Investor relations 1 hit
15
The chart highlights Carvykti's rapid growth compared to competitors like Kymriah, Yescarta, Tecartus, Breyanzi, and Abecma.Legend Biotech | Results Presentation Deck | 17 slides · Legend Biotech
Conference presentation Investor relations 1 hit
05
The chart uses horizontal bars to represent clinical trial phases for specific indications.MindMed | Investor Presentation Deck | 42 slides · MindMed
Pitch deck Investor relations Beat · Problem1 hit